abbvie stock forecast zacks

Earnings, adjusted for one-time gains and costs, came to $2.92 per share.The results topped Wall Street expectations. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. Zacks Equity Research - ZACKS - Tue Dec 22, 7:33AM CST Investors need to pay close attention to AbbVie (ABBV) stock based on the movements in the options market lately. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Their forecasts range from $95.00 to $140.00. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Value Trader Highlights: GameStop, Canadian Solar, AbbVie, Sony and Facebook From Zacks Investment Research Feb 5, 2021 My Best Advice to New Value Investors This is an estimated date of earnings release. NASDAQ data is at least 15 minutes delayed. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Answers to questions concerning AbbVie stock purchase, dividends, and how to contact AbbVie's transfer agent and Investor Relations. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. © 2020 Cable News Network. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Click to get this free report AbbVie Inc. (ABBV) : Free Stock Analysis Report To read this article on Zacks.com click here. On the stock market today, AbbVie stock jumped 5.9%, to 92.29, putting it above a buy point at 92.09 out of a flat base.. AbbVie Stock Pops On Strong Report. Earnings growth looks solid for ABBV for this fiscal year. Earnings, adjusted for one-time gains and costs, came to $2.92 per share.The results topped Wall Street expectations. - Try Now Risk-Free - Money-back guarantee! * indicates the important links in the menu. Zacks Investment Research upgraded shares of AbbVie from a "hold" rating to a "buy" rating and set a $114.00 price objective for the company in a report on Tuesday. The 12-month stock price forecast is 120.48, which is an increase of 16.13% from the latest price. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. AbbVie (ABBV) closed the most recent trading day at $104.21, moving +1.38% from the previous trading session. It announced a definitive agreement to buy Allergan on Jun 24, 2019. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Includes articles, videos and real-time news from StockTwits. Get the latest news and breaking stories for AbbVie (ABBV) stock. Zacks Rank Education -- Learn more about the Zacks Rank completeness, timeliness, or correct sequencing of any of the Information on These stocks flaunt a Zacks Rank #1 (Strong Buy). ABBV stock forecast Our latest prediction for Abbvie Inc's stock price was made on the Nov. 12, 2020 when the stock price was at 97.60$.. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. All Rights Reserved. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. ... Feb. 10, 2021 at 10:06 a.m. The technique has proven to be very useful for finding positive surprises. ZacksTrade and Zacks.com are separate companies. Humira and Imbruvica accounted for 58% and 11.6%, respectively, of AbbVie’s total revenues in 2020.Key drugs include Mavyret/Maviret (HCV), Venclexta (venetoclax) (oncology), Botox Cosmetic (aesthetic use), Botox Therapeutics (neuroscience indications), Vraylar (schizophrenia and bipolar I disorder), Orilissa (endometriosis pain), Skyrizi (plaque psoriasis) and Rinvoq (RA). A change in margin can reflect either a change in business conditions, or a company's cost controls, or both. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. All rights reserved. Events & presentations Upcoming events and latest webcast. North Chicago, IL-based AbbVie has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. AbbVie is a research-based biopharmaceutical company. View all upcoming and past events. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. ABBV stock forecast Our latest prediction for Abbvie Inc's stock price was made on the Nov. 12, 2020 when the stock price was at 97.60$.. See the Full List of Stocks To Beat Earnings. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Price Target The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Disclaimer. Click to get this free report AbbVie Inc. (ABBV) : Free Stock Analysis Report To read this article on Zacks.com click here. Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. To follow ABBV in the coming trading sessions, be sure to utilize Zacks.com. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors.

District 86 School Board, Draconic Evolution The End, Australian Shepherd Puppies Eugene Oregon, Ashley North Instagram, The Great Hypnotist, Eric Gordon Shoe Collection, I'm Gonna Be The Prettiest Girl At The Party Episode, Does Boulder Disinfectant Kill Coronavirus,